Skip to main content
LQDA
NASDAQ Life Sciences

Insider-affiliated entity files to sell $6.38M in Liquidia Corp stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$61.77
Mkt Cap
$5.493B
52W Low
$11.85
52W High
$62.17
52W Position info
421% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $11.85.

Summary

An insider-affiliated entity plans to sell $6.38 million in Liquidia Corp stock, continuing a trend of significant insider sales while the stock is near its 52-week high.


Key Events · Ownership and Investor Activity · LQDA

  • Proposed Insider Sale

    An entity with Director and Officer relationships to Liquidia Corp intends to sell 106,428 shares of common stock, valued at approximately $6.38 million.

  • Ongoing Insider Distribution

    This filing continues a pattern of significant insider selling, with the same entity having sold shares worth nearly $20 million in the past three months.

  • Trading Near 52-Week High

    The proposed sale occurs as Liquidia Corp's stock is trading near its 52-week high of $62.17, potentially indicating insiders are locking in gains.


Analysis · LQDA · Life Sciences

An entity associated with a director and officer of Liquidia Corp has filed a Form 144 to sell approximately $6.38 million worth of common stock. This proposed sale, following a pattern of significant insider selling totaling nearly $20 million in the past three months, occurs while the stock is trading near its 52-week high. This ongoing distribution by insiders could create an overhang on the stock.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1407 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LQDA was trading at $61.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $11.85 to $62.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Oct 13, 2026, 9:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.50
Real-time Price: $43.10 info
Change: +$3.60 (+9%) info
Market Cap: $3.982B info
LQDA
Oct 13, 2026, 5:50 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $31.76
Real-time Price: $43.10 info
Change: +$11.34 (+36%) info
Market Cap: $3.982B info
LQDA
Oct 02, 2026, 11:47 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $27.77
Real-time Price: $43.10 info
Change: +$15.33 (+55%) info
Market Cap: $3.982B info
LQDA
Oct 01, 2026, 12:03 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $26.22
Real-time Price: $43.10 info
Change: +$16.88 (+64%) info
Market Cap: $3.982B info
LQDA
Sep 30, 2026, 1:20 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $53.22
Real-time Price: $43.10 info
Change: -$10.12 (-19%) info
Market Cap: $3.982B info